Search

everythinglearnresearchcommunity

for

Search:↓

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Higher CRBP1 levels are linked to more severe alopecia areata.

Herbal lotions are effective for severe hair loss, with a 64.8% success rate, but relapse is common and long-term management requires allergen control and possible corticosteroid use.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib significantly improves hair regrowth in severe alopecia areata.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

The combined treatment helps improve severe hair loss and reduces the need for other medications.

More effective treatments are needed for severe alopecia areata.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Higher IL-17A levels indicate more severe alopecia areata.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Beard hair can be used for hair transplants in severe alopecia cases, with minimal complications and good results.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Botulinum toxin type A did not help regrow hair in severe alopecia cases.

Combining OMP with cyclosporine can effectively treat severe alopecia areata in children.

The treatment is effective and safe for severe alopecia areata in children, but not for total or universal hair loss.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

DPCP is more effective than tretinoin gel for treating severe alopecia.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Botulinum toxin type A injections are not effective for severe alopecia areata.